Page last updated: 2024-10-28

hydroxychloroquine and Autosomal Dominant Myotubular Myopathy

hydroxychloroquine has been researched along with Autosomal Dominant Myotubular Myopathy in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Pyridostigmine improved weakness in the centronuclear myopathy patient, but not in the distal myopathy patient."1.51Neuromuscular transmission defects in myopathies: Rare but worth searching for. ( Elahi, B; Laughlin, RS; Liewluck, T; Litchy, WJ; Milone, M, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elahi, B1
Laughlin, RS1
Litchy, WJ1
Milone, M1
Liewluck, T1

Other Studies

1 other study available for hydroxychloroquine and Autosomal Dominant Myotubular Myopathy

ArticleYear
Neuromuscular transmission defects in myopathies: Rare but worth searching for.
    Muscle & nerve, 2019, Volume: 59, Issue:4

    Topics: Cholinesterase Inhibitors; Cohort Studies; Electrodiagnosis; Electromyography; Female; Genetic Disea

2019